393 related articles for article (PubMed ID: 15331547)
1. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts.
Mazumder PK; O'Neill BT; Roberts MW; Buchanan J; Yun UJ; Cooksey RC; Boudina S; Abel ED
Diabetes; 2004 Sep; 53(9):2366-74. PubMed ID: 15331547
[TBL] [Abstract][Full Text] [Related]
2. Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.
Tabbi-Anneni I; Buchanan J; Cooksey RC; Abel ED
Endocrinology; 2008 Aug; 149(8):4043-50. PubMed ID: 18450963
[TBL] [Abstract][Full Text] [Related]
3. Myocardial function and energy substrate metabolism in the insulin-resistant JCR:LA corpulent rat.
Lopaschuk GD; Russell JC
J Appl Physiol (1985); 1991 Oct; 71(4):1302-8. PubMed ID: 1757353
[TBL] [Abstract][Full Text] [Related]
4. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.
Buchanan J; Mazumder PK; Hu P; Chakrabarti G; Roberts MW; Yun UJ; Cooksey RC; Litwin SE; Abel ED
Endocrinology; 2005 Dec; 146(12):5341-9. PubMed ID: 16141388
[TBL] [Abstract][Full Text] [Related]
5. Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice.
Hafstad AD; Khalid AM; How OJ; Larsen TS; Aasum E
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1288-94. PubMed ID: 17213470
[TBL] [Abstract][Full Text] [Related]
6. Central leptin signaling is required to normalize myocardial fatty acid oxidation rates in caloric-restricted ob/ob mice.
Sloan C; Tuinei J; Nemetz K; Frandsen J; Soto J; Wride N; Sempokuya T; Alegria L; Bugger H; Abel ED
Diabetes; 2011 May; 60(5):1424-34. PubMed ID: 21441440
[TBL] [Abstract][Full Text] [Related]
7. Fatty acids attenuate insulin regulation of 5'-AMP-activated protein kinase and insulin cardioprotection after ischemia.
Folmes CD; Clanachan AS; Lopaschuk GD
Circ Res; 2006 Jul; 99(1):61-8. PubMed ID: 16741157
[TBL] [Abstract][Full Text] [Related]
8. Myocardial mechanical dysfunction following endotoxemia: role of changes in energy substrate metabolism.
Soraya H; Masoud WG; Gandhi M; Garjani A; Clanachan AS
Basic Res Cardiol; 2016 Mar; 111(2):24. PubMed ID: 26926341
[TBL] [Abstract][Full Text] [Related]
9. Glucose and fatty acid metabolism in the isolated working mouse heart.
Belke DD; Larsen TS; Lopaschuk GD; Severson DL
Am J Physiol; 1999 Oct; 277(4):R1210-7. PubMed ID: 10516264
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of cardiac protein kinase B is regulated by palmitate.
Soltys CL; Buchholz L; Gandhi M; Clanachan AS; Walsh K; Dyck JR
Am J Physiol Heart Circ Physiol; 2002 Sep; 283(3):H1056-64. PubMed ID: 12181135
[TBL] [Abstract][Full Text] [Related]
11. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts.
Saddik M; Lopaschuk GD
J Biol Chem; 1991 May; 266(13):8162-70. PubMed ID: 1902472
[TBL] [Abstract][Full Text] [Related]
12. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity.
Boudina S; Sena S; O'Neill BT; Tathireddy P; Young ME; Abel ED
Circulation; 2005 Oct; 112(17):2686-95. PubMed ID: 16246967
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid oxidation and cardiac function in the sodium pivalate model of secondary carnitine deficiency.
Broderick TL; Christos SC; Wolf BA; DiDomenico D; Shug AL; Paulson DJ
Metabolism; 1995 Apr; 44(4):499-505. PubMed ID: 7723673
[TBL] [Abstract][Full Text] [Related]
14. Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer.
Mather KJ; Hutchins GD; Perry K; Territo W; Chisholm R; Acton A; Glick-Wilson B; Considine RV; Moberly S; DeGrado TR
Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E452-60. PubMed ID: 26732686
[TBL] [Abstract][Full Text] [Related]
15. Changes in substrate metabolism in isolated mouse hearts following ischemia-reperfusion.
Aasum E; Hafstad AD; Larsen TS
Mol Cell Biochem; 2003 Jul; 249(1-2):97-103. PubMed ID: 12956404
[TBL] [Abstract][Full Text] [Related]
16. CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes.
Angin Y; Steinbusch LK; Simons PJ; Greulich S; Hoebers NT; Douma K; van Zandvoort MA; Coumans WA; Wijnen W; Diamant M; Ouwens DM; Glatz JF; Luiken JJ
Biochem J; 2012 Nov; 448(1):43-53. PubMed ID: 22780108
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia.
Kuang M; Febbraio M; Wagg C; Lopaschuk GD; Dyck JR
Circulation; 2004 Mar; 109(12):1550-7. PubMed ID: 15023869
[TBL] [Abstract][Full Text] [Related]
18. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice.
Belke DD; Larsen TS; Gibbs EM; Severson DL
Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1104-13. PubMed ID: 11052966
[TBL] [Abstract][Full Text] [Related]
19. Postischemic recovery of heart metabolism and function: role of mitochondrial fatty acid transfer.
Montessuit C; Papageorgiou I; Tardy-Cantalupi I; Rosenblatt-Velin N; Lerch R
J Appl Physiol (1985); 2000 Jul; 89(1):111-9. PubMed ID: 10904042
[TBL] [Abstract][Full Text] [Related]
20. A novel partial fatty acid oxidation inhibitor decreases myocardial oxygen consumption and improves cardiac efficiency in demand-induced ischemic heart.
Wu L; Belardinelli L; Fraser H
J Cardiovasc Pharmacol; 2008 Apr; 51(4):372-9. PubMed ID: 18427280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
